Lactoferrin and lactoferricin peptides combat pathogens through multiple mechanisms — from iron sequestration to membrane disruption — with no known pathogen resistance and synergy with existing drugs.
Zero resistanceno pathogen has developed resistance to lactoferrin or lactoferricins
What the researchers found
Lactoferrin and lactoferricins combat pathogens through iron sequestration, membrane disruption, biofilm inhibition, toxin neutralization, and virulence factor inhibition, with no reported pathogen resistance and demonstrated synergy with antimicrobial drugs.
Why it matters
With antibiotic resistance threatening modern medicine, lactoferrin represents a multi-mechanism natural antimicrobial that pathogens haven't been able to evolve resistance against — a rare and valuable property.
The numbers in context
Multiple antimicrobial mechanisms documented: bacteriostatic, bactericidal, anti-biofilm, anti-virulence, immune-stimulating.
How the study worked
Comprehensive review of published literature on lactoferrin and lactoferricin antimicrobial mechanisms against bacteria, protozoa, fungi, and viruses.
Who was studied
Lactoferrin and lactoferrin-derived peptides across multiple pathogen models
What this study cannot tell us
Review focuses on in vitro and preclinical evidence — clinical trial data for lactoferrin as an antimicrobial therapy is limited. Optimal dosing, delivery methods, and clinical indications need further investigation.
How to read the evidence
Comprehensive review with extensive preclinical evidence. Clinical trial data is limited but the breadth of antimicrobial mechanisms is well-documented.
When this study was published
Published in 2020. Lactoferrin research has accelerated, particularly during and after the COVID-19 pandemic.
The bigger picture
The antimicrobial resistance crisis demands new approaches. Lactoferrin's multiple mechanisms of action, lack of resistance development, and synergy with existing drugs position it as both a standalone alternative and a combination therapy enhancer for drug-resistant infections.
Questions still open
- Can lactoferrin-based therapies be developed for clinical use against drug-resistant infections?
- What is the optimal combination of lactoferrin with existing antibiotics for different pathogen types?
- Could oral or topical lactoferrin formulations provide effective antimicrobial protection?
Common questions
Where does lactoferrin come from?
Why haven't pathogens developed resistance to lactoferrin?
Read the original research
Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.
Molecules (Basel, Switzerland), 25(24)
Citation
Zarzosa-Moreno, Daniela; Avalos-Gómez, Christian; Ramírez-Texcalco, Luisa Sofía; Torres-López, Erick; Ramírez-Mondragón, Ricardo; Hernández-Ramírez, Juan Omar; Serrano-Luna, Jesús; de la Garza, Mireya. (2020). Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.. Molecules (Basel, Switzerland), 25(24). https://doi.org/10.3390/molecules25245763